Literature DB >> 10193753

Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.

S Masunaga1, K Ono, H Hori, Y Kinashi, M Suzuki, M Takagaki, S Kasai, H Nagasawa, Y Uto.   

Abstract

C3H/He and Balb/c mice bearing SCC VII or EMT6/KU tumours received continuous administration of 5-bromo-2'-deoxyuridine (BrdU) for 5 days to label all proliferating (P) cells. The tumours were locally heated at 40 degrees C for 60 min and/or the tumour-bearing mice received intraperitoneal injection of nicotinamide, and then tirapazamine (TPZ) was injected intraperitoneally. Sixty minutes after TPZ injection, the tumours were excised, minced and trypsinized. The tumour cell suspensions were incubated with cytochalasin-B (a cytokinesis-blocker), and the micronucleus (MN) frequency in cells without BrdU labelling (quiescent (Q) cells) was determined using immunofluorescence staining for BrdU. The MN frequency in total (P+Q) tumour cells was determined from the tumours that were not pretreated with BrdU. The cytotoxicity of TPZ was evaluated in terms of the frequency of induced micronuclei in binuclear tumour cells (= MN frequency). In both tumour systems, the MN frequencies of Q cells were greater than those of total tumour cell populations. Mild heat treatment elevated the MN frequency in total and Q cells in both tumour systems, but the effect was more marked in Q cells. In total cells, mild heat treatment increased the MN frequency in EMT6/KU tumour cells more markedly than in SCC VII tumour cells. In contrast, in both tumour systems, nicotinamide decreased the MN frequency in both cell populations, with a greater influence on the total cells. The combination of TPZ and mild heat treatment may be useful for sensitizing tumour cells in vivo, including Q cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193753     DOI: 10.1080/026567399285819

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

1.  Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Hideko Nagasawa; Kenji Nagata; Minoru Suzuki; Yoshihiro Uto; Hitoshi Hori; Yuko Kinashi; Koji Ono
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-22       Impact factor: 4.553

Review 2.  Molecular parameters of hyperthermia for radiosensitization.

Authors:  Tej K Pandita; Shruti Pandita; Sukesh R Bhaumik
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 3.  Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review.

Authors:  E Y K Ng; S D Kumar
Journal:  Biomed Eng Online       Date:  2017-03-23       Impact factor: 2.819

4.  Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration.

Authors:  S Masunaga; K Ono; M Suzuki; Y Kinashi; M Takagaki; S Kasai; H Nagasawa; Y Uto; H Hori
Journal:  Jpn J Cancer Res       Date:  2000-07

5.  Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.

Authors:  S I Masunaga; K Ono; M Suzuki; Y Kinashi; M Takagaki; H Hori; S Kasai; H Nagasawa; Y Uto
Journal:  Jpn J Cancer Res       Date:  2000-05

6.  Effect of Tirapazamine, Metformin or Mild Hyperthermia on Recovery From Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cells.

Authors:  Shin-Ichiro Masunaga; Keizo Tano; Yu Sanada; Yoshinori Sakurai; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Tsubasa Watanabe; Takushi Takata; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2017-11-05

7.  An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.

Authors:  Shin-Ichiro Masunaga; Yu Sanada; Keizo Tano; Yoshinori Sakurai; Hiroki Tanaka; Takushi Takata; Minoru Suzuki; Koji Ono
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.